Exhibit 10.20
TELIK, INC.
June 12, 2009
Dr. Stefan Ryser,
Ph.D
c/o Telik, Inc.
3165 Porter Drive
Palo Alto, CA 94304
|
Re:
|
Transition
and Release Agreement
|
Dear Dr. Ryser:
This letter sets forth the terms and
conditions of the transition and release agreement (the “
Agreement ”) that Telik, Inc. (the “
Company ”) is offering to you.
1. Resignation of
Employment.
(a) Transition
Period. You will resign,
and the Company hereby accepts your resignation, as an employee of
the Company effective August 1, 2009 (the “
Transition Date ”). From the Effective Date of this
Agreement (as defined in Section 13(b) (ADEA Waiver) hereof)
through the Transition Date (the “ Transition Period
”), you will continue to serve as an employee of the Company
pursuant to the terms of your August 1, 2008 employment offer
letter agreement with the Company (the “ Employment
Agreement ”) and shall assist the Company, as reasonably
requested from time to time, in transitioning your responsibilities
and outstanding projects to other Company personnel. Except as
expressly provided this Agreement, you will no longer serve the
Company or any affiliated entity in any office or capacity after
the Transition Date.
(b) Proprietary
Information. You
acknowledge and agree to abide by your obligations under your
Proprietary Information and Inventions Agreement with the Company,
a copy of which is attached as Exhibit A hereto (the
“ Confidentiality Agreement ”), as well as any
other confidentiality obligations applicable to you pursuant to any
written agreement between you and the Company and/or under
applicable law.
(c) Final
Salary and Paid Time Off. On the Transition Date, the Company will pay you
all accrued salary and accrued but unused paid vacation earned by
you through the Transition Date, less applicable withholdings and
deductions.
(d) Expense
Reimbursements. You agree
that, within thirty (30) days after the Transition Date, you
shall submit your final documented expense reimbursement statement
reflecting all business expenses you incurred through the
Transition Date, if any, for which you seek reimbursement. The
Company will reimburse you for these expenses pursuant to its
regular business practice.
2. Stock
Options.
(a) Employment-Related
Option. In connection
with your employment with the Company, you were granted an option
(the “ Option ”) to purchase 325,000 shares of
Company common stock pursuant to the terms of the Company’s
2000 Equity Incentive Plan, as amended from time to time (the
“ Plan ”), and stock option grant notices and
agreements issued to you (collectively with the Plan, the “
Stock Documents ”). Pursuant to the Stock Documents,
75,000 shares subject to the Option were to become vested upon
achievement of specified performance objectives (the “
Performance-Based Shares ”); the remaining 250,000
shares (the “ Time-Based Shares ”) were to vest
over a four-year period, with twenty-five percent (25%) of the
Time-Based Shares becoming vested upon your completion of one
(1) year of continuous service with the Company, and the
remaining vesting in equal monthly installments for each month of
your continuous service thereafter. The shares subject to the
Option shall continue to vest through the Transition Date in
accordance with the current vesting schedule, at which time they
will cease vesting.
(b) Director
Options. In connection
with your service as a non-employee director of the Company, you
were granted options (the “ Director Options” )
to purchase 65,000 shares of the Company’s common stock
pursuant to the terms of the Company’s 2000 Non-Employee
Directors’ Stock Option Plan, as amended from time to time
(the “ Director Plan ”), and stock option grant
notices and agreements issued to you (collectively with the
Director Plan, the “ Director Stock Documents”
). The Director Options shall continue to vest through the
Transition Date in accordance with the applicable vesting schedules
set forth in the Director Stock Documents, at which time they will
cease vesting. Except to the extent modified herein, the Director
Options shall continue to be governed by the terms and conditions
set forth in the Director Stock Documents.
3. Severance
Benefits. Provided that
you (a) sign this Agreement and remain employed with the
Company pursuant to its terms through August 1, 2009, and
(b) sign and allow to become effective the Transition Date
Release attached hereto as Exhibit B , the Company
shall provide you with the severance benefits described below. You
must sign the Transition Date Release on or within 21-days after
the Transition Date (but not before the Transition Date), and allow
the Transition Date Release to become effective by its terms to
receive any of these benefits.
(a) Relocation
Benefits. The Company
shall forever waive any obligation on your part to reimburse the
Company for the Relocation Bonus (as defined in the Employment
Agreement) provided to you in connection with your employment with
the Company. In addition, the Company shall pay you a lump sum
relocation assistance payment of $40,000, less applicable
withholdings and deductions (the “ Relocation Assistance
Payment ”), to support you in relocating back to the New
York area. The Relocation Assistance Payment will be paid on the
first Company payroll pay date after your employment ends and you
have satisfied the Transition Date Release requirement described
above.
(b) COBRA.
Your group health insurance coverage
will end on the last day of the month in which the Transition Date
occurs (i.e., August 31, 2009). To the extent provided by
the
federal COBRA law or, if applicable, state
insurance laws, and by the Company’s current group health
insurance policies, you will be eligible to continue your group
health insurance benefits after that date at your own expense. You
will be provided additional information about your health insurance
continuation rights under separate cover on or shortly after the
Transition Date. Provided you timely elect to continue your health
insurance benefits after the Transition Date pursuant to the
federal COBRA law or, if applicable, state insurance laws, and by
the Company’s current group health insurance policies, as
additional compensation for the Services, the Company shall pay all
premiums necessary to maintain your current level of medical,
dental and vision insurance coverage in effect through the end of
the Consulting Period (as defined in Section 4(a) herein) or
until such earlier date as you secure replacement health, dental
and vision insurance coverage through a subsequent employer. You
agree to notify the Company as soon as possible after you secure
such replacement coverage.
4. Consulting Services
Agreement. Provided that
you (a) sign this Agreement and remain employed with the
Company pursuant to its terms through August 1, 2009, and
(b) sign and allow to become effective the Transition Date
Release attached hereto as Exhibit B as provided in
Section 3, then the Company will retain you as a consultant on
the terms and conditions set forth below.
(a) Consulting
Period. You shall serve
as a consultant to the Company from August 2, 2009 through
March 31, 2010 or until such earlier date as the consulting
arrangement is terminated as provided herein (the “
Consulting Period ”).
(b) Consulting
Services. As a
consultant, you will be responsible for providing advice and
analysis and other assistance and services with respect to
strategic matters as reasonably requested by the Company from time
to time (collectively, the “ Services ”). You
agree to make yourself available for up to 20 hours each month to
perform the Services, and agree to exercise the highest degree of
professionalism and utilize your expertise and creative talents in
performing the Services. The Services shall be assigned to you by
Cynthia M. Butitta, the Company’s Chief Operating Officer and
Chief Financial Officer, who will also serve as your primary
Company contact in your consultant role.
(c) Fees.
The Company will pay you consulting
fees (“ Fees ”) of $27,083.33 month for the
Services during the Consulting Period (with Fees for any partial
month of Services prorated based on the number of days of Services
provided). The Fees will be paid (via direct deposit to your
designated bank account) on or before the last day of each month
(e.g., payment for August will be made on August 31, 2009).
The Company will not make any withholdings from the Fees and will
issue you an IRS Form 1099 with respect to all Fees paid to you for
the Services. The Company will not make payments for state or
federal tax or social security; make unemployment insurance or
disability insurance contributions; or obtain workers’
compensation insurance for you. You hereby agree to accept
exclusive responsibility for complying with all applicable local,
state and federal laws governing self-employed individuals,
including obligations such as payment of taxes, social security,
disability and other contributions based on the Fees. You further
agree to indemnify and hold harmless the Company against any and
all liabilities to any taxing authority for any taxes, interest or
penalties arising in any way from the Fees.
(d) Expense
Reimbursement. The
Company will reimburse you for all documented business expenses
reasonably incurred in the course of performing the Services,
pursuant to its established expense reimbursement policies and
procedures in effect from time to time; provided, however, that you
agree that you will not incur any expense in excess of $100 without
the Company’s advance written consent.
(e) Independent
Contractor Relationship. Your relationship with the Company during the
Consulting Period shall be that of an independent contractor of the
Company, and not an employee of the Company. Accordingly, you will
not be entitled to receive any of the benefits the Company provides
to its employees generally. You will have no responsibilities or
authority as a consultant to the Company other than as specifically
provided in this Agreement. You shall not have any authority to
enter into any agreement or make any representation binding upon
the Company during the Consulting Period, and agree not to do so
unless expressly authorized by the Company, in writing, to do
so.
(f) Proprietary
Information. During the
Consulting Period, you may receive and develop confidential and
proprietary information relating to the Company’s business
practices, strategies and technologies (collectively, the “
Information ”). You acknowledge the confidential and
secret character of the Information, and agree that the Information
is the sole, exclusive and valuable property of Company.
Accordingly, you agree: (i) not to use, disclose or reproduce
any of the Information without the applicable prior written consent
of the Company, (ii) not to use the Information except in the
performance of your authorized duties for the Company, and
(iii) not to disclose all or any part of the Information in
any form to any third party. Upon the termination of the Consulting
Period or upon the Company’s earlier request, you agree to
cease using and to return to the Company all whole and partial
copies, reproductions, and derivatives of the Information, whether
in your possession or under your direct or indirect control.
Additionally, you hereby agree that any and all ideas,
improvements, inventions and works of authorship conceived,
written, created or first reduced to practice in your performance
of the Services shall be the sole and exclusive property of the
Company and you hereby assign to the Company all rights, title and
interest in and to any and all such ideas, improvements, inventions
and works of authorship. The foregoing obligations shall be in
addition to all continuing duties applicable to you under your
Confidentiality Agreement, and any other confidentiality
obligations applicable to you pursuant to any written agreement
between you and the Company, and/or under applicable
law.
(g) Early
Termination. The
Consulting Period may be terminated by you, at any time for any
reason, upon thirty (30) days’ advance written notice to
the Company. The Company may terminate the Consulting Period upon
any material breach by you of your obligations hereunder provided
such breach is not cured within seven (7) business days after
the Company issues you written notice to cure (pursuant to
Section 16 of this Agreement). Upon termination of the
Consulting Period, the Company shall pay you all Fees earned
through the end of the Consulting Period, and shall reimburse all
business expenses incurred by you in performance of the Services
through that date. (Final Fees will be prorated for any partial
month of service.)
(h) Acknowledgements.
You and the Company acknowledge and
agree that the consulting arrangement memorialized herein is not a
term or benefit required under the terms of the Employment
Agreement, and does not substitute in any way for any payments paid
or
otherwise payable to you under the Employment
Agreement. Rather, the foregoing consulting services agreement is a
new, legally binding right being created as of the date this
Agreement is signed by both parties (subject to your satisfaction
of the preconditions to receipt of this benefit, as set forth
herein).
5. Communications.
Except as otherwise authorized or
required by this Agreement, any statements or disclosures made by
either party to communicate your change in status (including the
reasons for your departure from the organization) shall be
consistent with the text attached hereto as Exhibit C
(the “ Statement ”) as well as the
parties’ other obligations under this Agreement (including
without limitation the obligations under Section 1(b)
(Proprietary Information) and Section 11 (Mutual
Nondisparagement) hereof). Notwithstanding any other provision of
this Agreement, the parties acknowledge that the Company may
disclose the material terms of this Agreement and publically file
the Agreement as required by applicable securities laws.
6. Quinolone-Mimetic
Program Acknowledgment. If, at any time within three (3) years
after the Transition Date, any scientific paper is issued by the
Company (in whole or in part) with respect to its
quinolone-mimetics program, the Company will identify you as a
co-author of such work.
7. No
Other Compensation or Benefits. Other than any vested rights you may have in any
Company-sponsored ERISA-covered benefit plan (i.e., a 401(k) plan
account), you will not receive any salary, bonuses, equity
interests or vesting, severance or any other form of compensation
or benefit from the Company after the Transition Date except as
expressly provided in this Agreement.
8. Company
Property.
(a) General
Obligations. On the
Transition Date and excluding the Service Materials (defined
below), you agree to return to the Company all Company documents
(and all copies thereof) and other Company property in your
possession or control, including, but not limited to, Company
files, notes, drawings, records, plans, forecasts, lists, reports,
studies, analyses, compilations of data, proposals, agreements,
operational and financial information, research and development
information, sales and marketing information, compensation and
personnel information, specifications, code, software, databases,
computer-recorded information, tangible property and equipment
(including, but not limited to, computers, facsimile machines,
mobile telephones, servers), credit cards, entry cards,
identification badges and keys; and any materials of any kind which
contain or embody any proprietary or confidential information of
the Company (and all reproductions thereof in whole or in part). If
you used any personal computer, server, or e-mail system to
receive, transmit, store or create any Company confidential or
proprietary data, materials or information in connection with your
employment with the Company, within thirty (30) days after the
Transition Date and excluding only Service Materials, you shall
provide the Company with a computer-useable copy of all such
confidential or proprietary data, materials or information, and
shall permanently delete and expunge such confidential or
proprietary information from those systems, and make any such
system available to the Company for inspection to ensure compliance
with this provision.
(b) Service
Materials. You shall be
entitled to temporarily retain all Company documents, electronic
files and other materials the Company expressly authorizes you in
writing
to retain in order to perform your services as a
consultant to the Company (collectively, the “ Service
Materials ”); provided, however, that you agree to return
all Service Materials to the Company at the end of the Consulting
Period or such other time requested by the Company. Within thirty
(30) days after the end of the Consulting Period, if you used
any personal computer, server, or e-mail system to receive,
transmit, store or create any Company confidential or proprietary
data, materials or information in connection with the performance
of your consulting services, you shall provide the Company with a
computer-useable copy of all such confidential or proprietary data,
materials or information, permanently delete and expunge such
confidential or proprietary information from those systems, and
make any such system available to the Company for inspection to
ensure compliance with this provision.
(c) Personal
Documents. Notwithstanding the foregoing, after the
Transition Date, you shall be entitled to retain as your personal
property: (i) all agreements between you and the Company that
you executed in connection with your employment with the Company;
(ii) all wage statements and other payroll records issued to
you, and well as documents issued to you with regard to your
employee benefits with the Company; and (iii) all Company
documents and information issued to you in connection with your
equity interests in the Company.
9. Noncompetition and
Work Activities. In order
to protect the trade secrets and confidential and proprietary
information of the Company, you agree that, during the remainder of
your employment with the Company and for entirety of the Consulting
Period, you will not, except on behalf of the Company, directly or
indirectly, whether as an officer, director, stockholder, member,
manager, partner, proprietor, employee, associate, representative,
consultant, or in any capacity whatsoever engage in, become
financially interested in, be employed or engaged by, or render
services to any other person, corporation, firm, partnership or
other entity whatsoever that is competitive with or is reasonably
anticipated to be competitive with the Company, nor make
preparations to do so; provided , however , that you
may own, as a passive investor, securities of any competitor, so
long as your holdings in any one such competitor shall not in the
aggregate constitute more than one percent (1%) of the
securities of such competitor (computed on a fully diluted basis
taking into account the possible conversion or exercise of any
convertible securities, options, warrants, or convertible debt).
Except as provided in the preceding sentence, you may engage in
other employment, consulting or other work relationships and
activities in addition to your continuing obligations to the
Company as long as such relationships and activities do not
unreasonably interfere with your obligations to the Company or
create an actual or apparent conflict of interest, each as
determined by the Company in its sole discretion which shall not be
unreasonably exercised. You further agree that, during the
remainder of your employment and throughout the Consulting Period,
except with the Company’s advance written consent, you will
not, directly or indirectly, contact or solicit any Company
customers for any purpose other than authorized Company
business.
10. Non-Interference.
During your employment and
subsequent consulting relationship with the Company and continuing
for twelve (12) months after the termination of such
relationship, you agree that you will not, directly or indirectly
by any means (including without limitation acting by or through any
other person or entity) solicit, induce, or attempt to induce any
employee, consultant, supplier, clinical investigator, clinical
site, or service provider of the Company to terminate or breach any
employment, contractual, or other business relationship with the
Company.
11. Mutual
Nondisparagement. During
the remainder of your employment with the Company and continuing at
all times thereafter, you agree not to disparage the Company or any
of its officers, directors, employees, shareholders, agents,
products or services, in any manner likely to be harmful to it,
their, his or her business, business reputation or personal
reputation. The Company (through its officers and directors) agrees
not to disparage you in any manner likely to be harmful to you,
your business, business reputation or personal reputation.
Notwithstanding the foregoing, nothing in this Agreement shall
prevent any person or entity from responding accurately and fully
to any request for information to which response is required by
legal process.
12. No
Adverse Action/Cooperation. You agree that you will not voluntarily provide
assistance, information or advice, directly or indirectly
(including through agents or attorneys), to any other person or
entity in connection with any claim or cause of action of any kind
brought against the Company; provided, however, that this
limitation shall not prevent you from pursuing a claim on your own
behalf (to the extent such claim is not released by you pursuant to
this Agreement or the Transition Date Release) or from providing
truthful and accurate testimony when requested by the Company or
required by subpoena. You further agree to cooperate fully with the
Company, as requested, in connection with the Company’s
actual or contemplated defense, prosecution, or investigation of
any claims or demands by third parties, or other matters, arising
from events, acts, or failures to act that occurred during your
board service or employment with the Company. Such cooperation
includes, without limitation, making yourself available upon
reasonable notice, without subpoena, for interviews and truthful
and accurate deposition and trial testimony. The Company will
reimburse you for reasonable, pre-approved and documented
out-of-pocket expenses incurred in connection with any such
cooperation (excluding any forgone wages, salary or other
compensation), and will reasonably accommodate your scheduling
needs.
13. Release of
Claims.
(a) Ryser
Release. In exchange for
the Company’s agreement to the terms set forth herein, you
hereby release the Company, its successors, predecessors, parents,
subsidiaries, and affiliates, and each of such
entities&rsquo